Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 384

1.

Agomelatine, a melatonin agonist with antidepressant properties.

Dubovsky SL, Warren C.

Expert Opin Investig Drugs. 2009 Oct;18(10):1533-40. doi: 10.1517/13543780903292634. Review.

PMID:
19758108
[PubMed - indexed for MEDLINE]
2.

Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.

Kasper S, Hamon M.

World J Biol Psychiatry. 2009;10(2):117-26. doi: 10.1080/15622970902717024. Review.

PMID:
19255935
[PubMed - indexed for MEDLINE]
3.

[Agomelatine: the first "melatoninergic" antidepressant].

Bánki MC.

Neuropsychopharmacol Hung. 2006 Oct;8(3):105-12. Review. Hungarian.

PMID:
17211046
[PubMed - indexed for MEDLINE]
4.

Treating each and every depressed patient.

Kennedy SH.

J Psychopharmacol. 2008 Sep;22(7 Suppl):19-23. doi: 10.1177/0269881108093270. Review.

PMID:
18753279
[PubMed - indexed for MEDLINE]
5.

Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.

San L, Arranz B.

Eur Psychiatry. 2008 Sep;23(6):396-402. doi: 10.1016/j.eurpsy.2008.04.002. Epub 2008 Jun 25. Review.

PMID:
18583104
[PubMed - indexed for MEDLINE]
6.

Agomelatine: innovative pharmacological approach in depression.

Popoli M.

CNS Drugs. 2009;23 Suppl 2:27-34. doi: 10.2165/11318640-000000000-00000. Review.

PMID:
19708723
[PubMed - indexed for MEDLINE]
7.

Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.

Bourin M, Prica C.

Curr Pharm Des. 2009;15(14):1675-82. Review.

PMID:
19442180
[PubMed - indexed for MEDLINE]
8.

Agomelatine: a preliminary review of a new antidepressant.

Zupancic M, Guilleminault C.

CNS Drugs. 2006;20(12):981-92. Review.

PMID:
17140278
[PubMed - indexed for MEDLINE]
9.

Addressing circadian rhythm disturbances in depressed patients.

Lam RW.

J Psychopharmacol. 2008 Sep;22(7 Suppl):13-8. doi: 10.1177/0269881108092591. Review.

PMID:
18753278
[PubMed - indexed for MEDLINE]
10.

Agomelatine, an innovative pharmacological response to unmet needs.

Le Strat Y, Gorwood P.

J Psychopharmacol. 2008 Sep;22(7 Suppl):4-8. doi: 10.1177/0269881108092593. Review.

PMID:
18753276
[PubMed - indexed for MEDLINE]
11.

The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine.

De Berardis D, Di Iorio G, Acciavatti T, Conti C, Serroni N, Olivieri L, Cavuto M, Martinotti G, Janiri L, Moschetta FS, Conti P, Di Giannantonio M.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):119-32. Review.

PMID:
20874703
[PubMed - indexed for MEDLINE]
12.

Agomelatine: efficacy at each phase of antidepressant treatment.

Kennedy SH.

CNS Drugs. 2009;23 Suppl 2:41-7. doi: 10.2165/11318660-000000000-00000. Review.

PMID:
19708725
[PubMed - indexed for MEDLINE]
13.

The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.

Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.

World J Biol Psychiatry. 2009;10(4 Pt 2):342-54. doi: 10.1080/15622970701625600. Review.

PMID:
18609422
[PubMed - indexed for MEDLINE]
14.

Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system.

Fuchs E, Simon M, Schmelting B.

Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S17-20. Review.

PMID:
16436935
[PubMed - indexed for MEDLINE]
15.

Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.

Olié JP, Kasper S.

Int J Neuropsychopharmacol. 2007 Oct;10(5):661-73. Epub 2007 May 4.

PMID:
17477888
[PubMed - indexed for MEDLINE]
16.

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.

Hale A, Corral RM, Mencacci C, Ruiz JS, Severo CA, Gentil V.

Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. doi: 10.1097/YIC.0b013e32833a86aa.

PMID:
20856123
[PubMed - indexed for MEDLINE]
17.

Agomelatine in the treatment of seasonal affective disorder.

Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S.

Psychopharmacology (Berl). 2007 Mar;190(4):575-9. Epub 2006 Dec 15.

PMID:
17171557
[PubMed - indexed for MEDLINE]
18.

The use of antidepressants in clinical practice: focus on agomelatine.

McAllister-Williams RH, Baldwin DS, Haddad PM, Bazire S.

Hum Psychopharmacol. 2010 Mar;25(2):95-102. doi: 10.1002/hup.1094. Review.

PMID:
20196187
[PubMed - indexed for MEDLINE]
19.

Major depression is sometimes described as the common cold of psychiatry.

Goodwin GM.

J Psychopharmacol. 2008 Sep;22(7 Suppl):3. doi: 10.1177/0269881108094716. No abstract available.

PMID:
18753275
[PubMed - indexed for MEDLINE]
20.

Circadian rhythms, melatonin and depression.

Quera Salva MA, Hartley S, Barbot F, Alvarez JC, Lofaso F, Guilleminault C.

Curr Pharm Des. 2011;17(15):1459-70. Review.

PMID:
21476953
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk